We further found that the TAK1 inhibitor takinib triggered RIPK1 upregulation, astrocyte and microglial activation, hippocampal neuroinflammation and cognitive impairment after surgery, but these changes were reversed by the RIPK1 inhibitor Nec-1 in young rats. This evidence concerns the gene MAP3K7 and Cognitive impairment.